Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash Items
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silo Pharma (SILO) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for Silo Pharma (SILO) over the last 13 years, with Q3 2025 value amounting to -$416045.0.

  • Silo Pharma's Net Cash Flow fell 21733.13% to -$416045.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.0 million, marking a year-over-year decrease of 16516.17%. This contributed to the annual value of $381491.0 for FY2024, which is 10486.43% up from last year.
  • Silo Pharma's Net Cash Flow amounted to -$416045.0 in Q3 2025, which was down 21733.13% from -$897166.0 recorded in Q2 2025.
  • In the past 5 years, Silo Pharma's Net Cash Flow registered a high of $6.1 million during Q3 2021, and its lowest value of -$6.7 million during Q1 2023.
  • In the last 5 years, Silo Pharma's Net Cash Flow had a median value of -$485611.0 in 2021 and averaged -$216563.6.
  • Its Net Cash Flow has fluctuated over the past 5 years, first skyrocketed by 351894.96% in 2021, then crashed by 121259.44% in 2023.
  • Over the past 5 years, Silo Pharma's Net Cash Flow (Quarter) stood at -$424415.0 in 2021, then plummeted by 108.76% to -$885989.0 in 2022, then skyrocketed by 475.23% to $3.3 million in 2023, then crashed by 128.73% to -$955091.0 in 2024, then surged by 56.44% to -$416045.0 in 2025.
  • Its last three reported values are -$416045.0 in Q3 2025, -$897166.0 for Q2 2025, and -$768919.0 during Q1 2025.